Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation

Ischemic stroke is the most widespread cause of disability and a leading cause of death in developed countries. To date, the most potent approved treatment for acute stroke is recanalization therapy with thrombolytic drugs such as tissue plasminogen activator (rt-PA or tPA) or endovascular mechanica...

全面介紹

Na minha lista:
書目詳細資料
發表在:Front Neurol
Main Authors: Lyden, Patrick D., Pryor, Kent E., Minigh, Jennifer, Davis, Thomas P., Griffin, John H., Levy, Howard, Zlokovic, Berislav V.
格式: Artigo
語言:Inglês
出版: Frontiers Media S.A. 2021
主題:
Neurology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8005555/
https://ncbi.nlm.nih.gov/pubmed/33790846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2021.593582
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍